Description

CIPLAR LA 40 MG (1X15)

Indications

CIPLAR LA 40 MG is primarily indicated for the management of hypertension and the treatment of angina pectoris. It is often prescribed as part of a comprehensive treatment plan that may include lifestyle modifications and other antihypertensive medications. The extended-release formulation allows for once-daily dosing, which enhances patient compliance and convenience.

Mechanism of Action

The active ingredient in CIPLAR LA is propranolol, a non-selective beta-adrenergic antagonist. Propranolol works by blocking the action of endogenous catecholamines (such as epinephrine and norepinephrine) at beta-adrenergic receptors in various tissues, including the heart and blood vessels. This action leads to a decrease in heart rate, myocardial contractility, and cardiac output, ultimately resulting in lowered blood pressure. Additionally, propranolol reduces the frequency and severity of angina attacks by decreasing myocardial oxygen demand.

Pharmacological Properties

CIPLAR LA exhibits several pharmacological properties that contribute to its therapeutic effects. It has a high lipid solubility, which allows it to cross the blood-brain barrier and exert effects on the central nervous system. Propranolol also has antiarrhythmic properties, making it useful in managing certain types of cardiac arrhythmias. The extended-release formulation ensures a steady release of the drug over 24 hours, maintaining therapeutic plasma levels and minimizing fluctuations that can lead to side effects.

Contraindications

CIPLAR LA is contraindicated in patients with a known hypersensitivity to propranolol or any of its components. It should not be used in individuals with severe bradycardia, heart block greater than first degree, cardiogenic shock, or decompensated heart failure. Patients with a history of asthma or chronic obstructive pulmonary disease (COPD) should also avoid this medication due to the risk of bronchospasm. Additionally, caution is advised in patients with diabetes, as propranolol may mask the symptoms of hypoglycemia.

Side Effects

Common side effects associated with CIPLAR LA include fatigue, dizziness, and gastrointestinal disturbances such as nausea and diarrhea. Some patients may experience sleep disturbances, including insomnia or vivid dreams. More serious side effects can occur, including bradycardia, hypotension, and exacerbation of respiratory conditions in sensitive individuals. It is important for patients to report any unusual or severe side effects to their healthcare provider promptly.

Dosage and Administration

The usual starting dose of CIPLAR LA for adults is 40 mg once daily, which may be adjusted based on the patient’s response and clinical condition. For hypertension, the dose may be increased to 80 mg or more, depending on the patient’s blood pressure response. In the case of angina, the maximum recommended dose is typically 240 mg per day. It is important to take CIPLAR LA with food to enhance absorption and to swallow the tablets whole without chewing or crushing. Patients should adhere to their prescribed dosing schedule and consult their healthcare provider before making any changes.

Interactions

CIPLAR LA may interact with several medications, potentially altering their effects. Co-administration with other antihypertensive agents can lead to additive effects, resulting in excessive hypotension. Caution is advised when using propranolol with medications that affect hepatic metabolism, such as cimetidine or certain antidepressants, as these can increase propranolol levels in the blood. Additionally, nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce the antihypertensive effect of propranolol. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and supplements.

Precautions

Before starting CIPLAR LA, patients should undergo a thorough medical evaluation to identify any underlying health conditions that may affect treatment. Special care should be taken in patients with a history of liver disease, as hepatic impairment can lead to increased drug levels and potential toxicity. Patients with a history of depression should also be monitored closely, as beta-blockers can sometimes exacerbate depressive symptoms. Abrupt discontinuation of propranolol may lead to rebound hypertension or worsening angina; therefore, any changes in therapy should be made gradually under medical supervision.

Clinical Studies

Clinical studies have demonstrated the efficacy of propranolol in reducing blood pressure and managing angina symptoms. In a randomized controlled trial, patients treated with propranolol experienced significant reductions in both systolic and diastolic blood pressure compared to placebo. Additionally, studies have shown that propranolol effectively decreases the frequency of angina attacks and improves exercise tolerance in patients with stable angina. Long-term studies have also indicated that propranolol can reduce the risk of cardiovascular events in patients with a history of myocardial infarction.

Conclusion

CIPLAR LA 40 MG is a valuable medication for the management of hypertension and angina pectoris. Its unique pharmacological properties and extended-release formulation make it an effective option for patients requiring long-term treatment. However, careful consideration of contraindications, potential side effects, and drug interactions is essential to ensure safe and effective use. Patients should maintain open communication with their healthcare providers to optimize their treatment regimen and address any concerns that may arise during therapy.